Linda C. Hogan
Fondateur chez LLH & Associates LLC
Provenance du réseau au premier degré de Linda C. Hogan
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Subsidiary | Biotechnology | 17 | |
Care Capital LLC
 Care Capital LLC Investment ManagersFinance Care Capital LLC (care capital) is a venture capital firm founded in 2001 by Jan Leschly and David Ramsay. The firm is headquartered in Princeton, New Jersey.
2
| Private Company | Investment Managers | 2 |
LLH & Associates LLC
 LLH & Associates LLC Miscellaneous Commercial ServicesCommercial Services LLH & Associates LLC provides professional consulting services. The firm specializes in tailoring services to fit specific customer requirements. The company was founded in 2001 and is headquartered in Toano, VA.
1
| Private Company | Miscellaneous Commercial Services | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Linda C. Hogan via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Director of Finance/CFO Corporate Officer/Principal Corporate Secretary | |
| MERCK & CO., INC. | Pharmaceuticals: Major | President Corporate Officer/Principal | |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 1984 and is headquartered in Marlborough, MA. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| NPS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
RealMed Corp.
 RealMed Corp. Regional BanksFinance RealMed Corp. provides health care administration solutions which use Internet to automate health care transactions and information exchange between providers, payers, and patients. Its revenue cycle management is a menu of services extended to clients, both payers and providers, which include claims preparation, management, and payments as well as accounts receivable management. The company was founded in 1995 and is headquartered in Indianapolis, IN. | Regional Banks | Corporate Officer/Principal | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| GLOBEIMMUNE, INC. | Pharmaceuticals: Other | Director/Board Member | |
Cary Street Partners LLC
 Cary Street Partners LLC Investment ManagersFinance Cary Street Partners LLC provides wealth management and investment banking services. It offers research & portfolio advisory, financial planning, insurance & estate planning and investment banking services. The company was founded by Mark M. Gambill and Thomas H. Tullidge Jr. in 2002 and is headquartered in Richmond, VA. | Investment Managers | Director/Board Member | |
| RENEURON GROUP PLC | Pharmaceuticals: Major | Chief Executive Officer | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| WAVE LIFE SCIENCES LTD. | Biotechnology | Director/Board Member | |
Polaris Growth Management LLC
 Polaris Growth Management LLC Investment ManagersFinance Polaris Partners is an Independent Venture Capital firm founded in 1996 by Stephen D. Arnold, Jonathan A. Flint and Terrance G. McGuire. Polaris Partners is headquartered in Waltham. | Investment Managers | Private Equity Investor | |
Lippincott Williams & Wilkins, Inc.
 Lippincott Williams & Wilkins, Inc. Publishing: Books/MagazinesConsumer Services Lippincott Williams & Wilkins, Inc. Publishes health information for physicians, nurses, specialized clinicians and students. The company publishes the information in print format (textbooks, journals) as well as electronic formats (CD-ROM, Internet, and intranets). The company was founded in 1890 and is headquartered in Philadelphia, PA. | Publishing: Books/Magazines | Corporate Officer/Principal | |
| University of Oxford | College/University | Undergraduate Degree | |
| The University of Manchester | College/University | Doctorate Degree | |
| Butler University | College/University | Director/Board Member Director/Board Member | |
LV Management Group, LLC
 LV Management Group, LLC Investment ManagersFinance Lilly Ventures Management Group LLC (Lilly ventures) is a venture capital firm, a subsidiary of Eli Lilly & Co. founded in 2001 by S.Edward Torres and Ron Laufer. The firm is headquartered in Indianapolis,Indiana. | Investment Managers | Chief Investment Officer | |
| Syracuse University | College/University | Graduate Degree | |
| University of Tennessee | College/University | Masters Business Admin Undergraduate Degree | |
Hydra Biosciences, Inc.
 Hydra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Hydra Biosciences, Inc. develops pharmaceutical products. It is focused in major therapeutic areas, which include pain, inflammation, renal, anxiety, and pulmonary diseases. The company was founded by Laurie Bartlett Keating, Dean Y. Li, David E. Clapham, and Mark T. Keating in 2001 and is headquartered in Belmont, MA. | Pharmaceuticals: Major | Director/Board Member | |
ReNeuron Ltd.
 ReNeuron Ltd. BiotechnologyHealth Technology ReNeuron Ltd. researches and develops drugs, diagnostics, and other therapeutic products. The company was founded on May 23, 1997 and is headquartered in Bridgend, the United Kingdom. | Biotechnology | Chief Executive Officer | |
| University of Warwick | College/University | Masters Business Admin | |
| Scandinavian International Management Institute | College/University | Corporate Officer/Principal | |
| HealthCare Institute of New Jersey | Director/Board Member Director/Board Member | ||
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Symphogen A/S
 Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Chairman | |
| Hoechst Marion Roussel, Inc. | Corporate Officer/Principal President | ||
| TREVENA, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
The Bioindustry Association
 The Bioindustry Association Miscellaneous Commercial ServicesCommercial Services The BioIndustry Association is a UK-based organization that represents the life sciences and biotech industry. The British company's mission is to facilitate and connect the ecosystem to help businesses start, grow, and deliver world-changing innovation. The non-profit company was founded by Cormac G. Kilty and Simon Geoffrey Best, and Steve Bates has been the CEO of the company since 2012. | Miscellaneous Commercial Services | Director/Board Member | |
Vantia Ltd.
 Vantia Ltd. Miscellaneous Commercial ServicesCommercial Services Vantia Ltd. services to provide molecule agonists of vasopressin receptors. It offers healthcare improve clinical treatments through development and commercialization of innovative medicines. The company was founded by Robert Haigh and Chris Yea in 2008 and is headquartered in Southampton, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Tarsa Therapeutics, Inc.
 Tarsa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tarsa Therapeutics, Inc. engages in the development of therapies for the treatment and prevention of osteoporosis and related bone diseases. Its product OSTORA, is an oral formulation of calcitonin, which is a recombinant peptide hormone that inhibits bone resorption. The company was founded by David Brand and James Gilligan in 2009 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Director/Board Member | |
| Maxwell School of Syracuse University | College/University | Graduate Degree | |
| LOXO ONCOLOGY INC | Pharmaceuticals: Major | President | |
| ARMO BIOSCIENCES INC | Pharmaceuticals: Major | President | |
| Institute of Psychiatry, Psychology & Neuroscience | College/University | Doctorate Degree | |
Perseus Holdings USA LLC
 Perseus Holdings USA LLC Electronics DistributorsDistribution Services Perseus Holdings USA LLC markets vaccine platform technology. The company is headquartered in Austin, TX. | Electronics Distributors | Director/Board Member | |
| NABRIVA THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member | |
Tremeau Pharmaceuticals, Inc.
 Tremeau Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tremeau Pharmaceuticals, Inc. engages in the developing and delivering of non-opioid pain therapies. The firm product includes TRM-201 (rofecoxib). The company was founded by Bradford C. Sippy and Mark H. N. Corrigan in 2016 and is headquartered in Concord, MA. | Pharmaceuticals: Major | Chief Executive Officer | |
Noema Pharma AG
 Noema Pharma AG BiotechnologyHealth Technology Noema Pharma AG is a biotechnology company, which engages in the development of orphan neurological disorder therapies. It focuses on understanding and meeting patient needs using novel therapies. The company was founded by Luigi Costa and George Garibaldi and is headquartered in Basel, Switzerland. | Biotechnology | Director/Board Member | |
Exacis Biotherapeutics, Inc.
 Exacis Biotherapeutics, Inc. Medical/Nursing ServicesHealth Services Part of Eterna Therapeutics, Inc., Exacis Biotherapeutics, Inc. is a development stage immuno-oncology company based in Cambridge, MA. Exacis uses its proprietary-based technologies to engineer next generation off-the-shelf NK and T cell therapies aimed at liquid and solid tumors. Exacis has an exclusive license to the Factor Bioscience technology for engineered NK and T cell products derived from iPSCs for use in oncology and holds all development and commercial rights for these investigational candidates. Exacis' approach avoids the use of DNA and viruses and instead uses a proprietary-based technology to generate iPSCs and to edit their genome to create stealthed, performance-enhanced allogeneic NK and T cell products, termed ExANK™, Exacar-NK™, and Exacar-T™ cells. The company was founded in 2020 by Gregory Fiore, Matthew Angel, James Pan. Gregory Fiore has been the CEO since 2020. Exacis Biotherapeutics was acquired by Eterna Therapeutics, Inc. on May 02, 2023 for $49 million. | Medical/Nursing Services | Chairman |
Statistiques
Internationale
| Etats-Unis | 36 |
| Royaume-Uni | 11 |
| Danemark | 3 |
| Singapour | 2 |
| Irlande | 2 |
Sectorielle
| Health Technology | 28 |
| Consumer Services | 11 |
| Finance | 5 |
| Commercial Services | 4 |
| Health Services | 3 |
Opérationnelle
| Director/Board Member | 175 |
| Corporate Officer/Principal | 49 |
| Independent Dir/Board Member | 47 |
| Chairman | 27 |
| President | 24 |
Relations les plus connectées
| Insiders | |
|---|---|
| Martin Edwards | 38 |
| Jesse I. Treu | 38 |
| Luc Marengère | 31 |
| Mark Corrigan | 29 |
| Francois Nader | 28 |
| Alison Lawton | 25 |
| Marvin White | 23 |
| Thomas Mathers | 19 |
| Richard Markham | 17 |
| Darren J. Carroll | 13 |
| Joshua Smiley | 10 |
| Timothy C. Gupton | 9 |
| Bernice Kuca | 9 |
| Nadia M. J. Rupniak | 6 |
| Rachel D. Jonas | 6 |
- Bourse
- Insiders
- Linda C. Hogan
- Connexions Sociétés
